Literature DB >> 34750537

Intraoperative imaging in pathology-assisted surgery.

Floris J Voskuil1,2, Jasper Vonk1, Bert van der Vegt2, Schelto Kruijff3,4, Vasilis Ntziachristos5,6, Pieter J van der Zaag7,4,8, Max J H Witjes1, Gooitzen M van Dam9,10.   

Abstract

The pathological assessment of surgical specimens during surgery can reduce the incidence of positive resection margins, which otherwise can result in additional surgeries or aggressive therapeutic regimens. To improve patient outcomes, intraoperative spectroscopic, fluorescence-based, structural, optoacoustic and radiological imaging techniques are being tested on freshly excised tissue. The specific clinical setting and tumour type largely determine whether endogenous or exogenous contrast is to be detected and whether the tumour specificity of the detected biomarker, image resolution, image-acquisition times or penetration depth are to be prioritized. In this Perspective, we describe current clinical standards for intraoperative tissue analysis and discuss how intraoperative imaging is being implemented. We also discuss potential implementations of intraoperative pathology-assisted surgery for clinical decision-making.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34750537     DOI: 10.1038/s41551-021-00808-8

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   25.671


  140 in total

1.  The clinical significance of the positive surgical margin in oral cancer.

Authors:  Abdulaziz Binahmed; Richard W Nason; Ahmed A Abdoh
Journal:  Oral Oncol       Date:  2006-12-14       Impact factor: 5.337

Review 2.  Intraoperative imaging in ovarian cancer: fact or fiction?

Authors:  Lucia M A Crane; Marleen van Oosten; Rick G Pleijhuis; Arash Motekallemi; Sean C Dowdy; William A Cliby; Ate G J van der Zee; Gooitzen M van Dam
Journal:  Mol Imaging       Date:  2011-04-26       Impact factor: 4.488

3.  Evaluation of frozen section margins in high-risk cutaneous squamous cell carcinomas of the head and neck.

Authors:  Kyle J Chambers; Stefan Kraft; Kevin Emerick
Journal:  Laryngoscope       Date:  2014-09-17       Impact factor: 3.325

Review 4.  Systematic Review of Pelvic Exenteration With En Bloc Sacrectomy for Recurrent Rectal Adenocarcinoma: R0 Resection Predicts Disease-free Survival.

Authors:  Amarasingam Sasikumar; Chetan Bhan; John T Jenkins; Anthony Antoniou; Jamie Murphy
Journal:  Dis Colon Rectum       Date:  2017-03       Impact factor: 4.585

5.  Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.

Authors:  Meena S Moran; Stuart J Schnitt; Armando E Giuliano; Jay R Harris; Seema A Khan; Janet Horton; Suzanne Klimberg; Mariana Chavez-MacGregor; Gary Freedman; Nehmat Houssami; Peggy L Johnson; Monica Morrow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-01       Impact factor: 7.038

6.  Circumferential margin plays an independent impact on the outcome of rectal cancer patients receiving curative total mesorectal excision.

Authors:  Hung-Hsin Lin; Jen-Kou Lin; Chun-Chi Lin; Yuan-Tzu Lan; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin; Wen-Yih Liang; Shih-Ching Chang
Journal:  Am J Surg       Date:  2013-07-17       Impact factor: 2.565

7.  The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.

Authors:  Koen C M J Peeters; Corrie A M Marijnen; Iris D Nagtegaal; Elma Klein Kranenbarg; Hein Putter; Theo Wiggers; Harm Rutten; Lars Pahlman; Bengt Glimelius; Jan Willem Leer; Cornelis J H van de Velde
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

8.  Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.

Authors:  Funda Meric; Nadeem Q Mirza; Georges Vlastos; Thomas A Buchholz; Henry M Kuerer; Gildy V Babiera; S Eva Singletary; Merrick I Ross; Frederick C Ames; Barry W Feig; Savitri Krishnamurthy; George H Perkins; Marsha D McNeese; Eric A Strom; Vicente Valero; Kelly K Hunt
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

9.  Ex vivo indocyanine green fluorescence imaging for the detection of lymph node involvement in advanced-stage ovarian cancer.

Authors:  Catalin-Florin Pop; Isabelle Veys; Maria Gomez Galdon; Michel Moreau; Denis Larsimont; Vincent Donckier; Pierre Bourgeois; Gabriel Liberale
Journal:  J Surg Oncol       Date:  2018-10-07       Impact factor: 3.454

10.  The prognostic implications of the surgical margin in oral squamous cell carcinoma.

Authors:  D N Sutton; J S Brown; S N Rogers; E D Vaughan; J A Woolgar
Journal:  Int J Oral Maxillofac Surg       Date:  2003-02       Impact factor: 2.789

View more
  5 in total

1.  CoreView: fresh tissue biopsy assessment at the bedside using a millifluidic imaging chip.

Authors:  David J Cooper; Chuqin Huang; Dylan A Klavins; Mark E Fauver; Matthew D Carson; Farzad Fereidouni; Suzanne Dintzis; Csaba Galambos; Richard M Levenson; Eric J Seibel
Journal:  Lab Chip       Date:  2022-03-29       Impact factor: 6.799

Review 2.  Cysteine Cathepsins in Breast Cancer: Promising Targets for Fluorescence-Guided Surgery.

Authors:  Daan G J Linders; Okker D Bijlstra; Laura C Fallert; Denise E Hilling; Ethan Walker; Brian Straight; Taryn L March; A Rob P M Valentijn; Martin Pool; Jacobus Burggraaf; James P Basilion; Alexander L Vahrmeijer; Peter J K Kuppen
Journal:  Mol Imaging Biol       Date:  2022-08-24       Impact factor: 3.484

3.  Freehand scanning photoacoustic microscopy with simultaneous localization and mapping.

Authors:  Jiangbo Chen; Yachao Zhang; Jingyi Zhu; Xu Tang; Lidai Wang
Journal:  Photoacoustics       Date:  2022-10-07

4.  Epidermal Growth Factor Receptor-Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer.

Authors:  Jasper Vonk; Jaron G de Wit; Floris J Voskuil; Yang Hang Tang; Wouter T R Hooghiemstra; Matthijs D Linssen; Evert van den Broek; Jan J Doff; Sebastiaan A H J de Visscher; Kees-Pieter Schepman; Bert van der Vegt; Gooitzen M van Dam; Max J H Witjes
Journal:  J Nucl Med       Date:  2021-09-16       Impact factor: 11.082

Review 5.  The use of oncolytic virotherapy in the neoadjuvant setting.

Authors:  Raquela J Thomas; Eric Bartee
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 13.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.